EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Identification and Validation of Four Serum Biomarkers With Optimal Diagnostic and Prognostic Potential for Gastric Cancer Based on Machine Learning Algorithms

Yi Liu, Bingxian Bian, Shiyu Chen, Bingqian Zhou, Peng Zhang, Lisong Shen, Hui Chen iD

Cancer Medicine · 2025

DOI: 10.1002/cam4.70659 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Cancer Medicine, 2025. Verfasst von Yi Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Biomarkers, Tumor, Machine Learning. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Key Clinical Specialty Construction Project, Shanghai Sailing Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastric cancer (GC) is considered a highly heterogeneous disease, and currently, a comprehensive approach encompassing molecular data from various biological levels is lacking.

Methods

This study conducted different analyses, including the identification of differentially expressed genes (DEGs), weighted correlation networks (WGCNA), single‐cell RNA sequencing (scRNA‐seq), mRNA expression‐based stemness index (mRNAsi), and multiCox analysis, utilizing data from Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases. Subsequently, the machine learning algorithms including least absolute shrinkage and selection operator (LASSO) regression and random forest (RF), combined with multiCox analysis were exploited to identify hub genes. These findings were then validated through the receiver operating characteristic (ROC) curve and Kaplan–Meier analysis, and were experimentally confirmed in GC samples by reverse transcription–polymerase chain reaction (RT‐PCR) and enzyme‐linked immunosorbent assay (ELISA).

Results

Integrated analysis of TCGA and GEO databases, coupled with LASSO regression and RF algorithms, allowed us to identify 18 hub genes encoding differentially expressed secreted proteins in GC. The results of RT‐PCR and bioinformatics analysis revealed four promising biomarkers with optimal diagnostic and prognostic potential. ROC analysis and Kaplan–Meier curves highlighted CHI3L1, FCGBP, VSIG2, and TFF2 as promising biomarkers for GC, offering superior modeling accuracy. These findings were further confirmed by RT‐PCR and ELISA, affirming the clinical utility of these four biomarkers. Additionally, CIBERSORT analysis indicated a potential correlation between the four biomarkers and the infiltration of B memory cells and Treg cells.

Conclusion

This study unveiled four promising biomarkers present in the serum of patients with GC, which could serve as powerful indicators of GC and provide valuable insights for further research into GC pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsBiomarkers, TumorMachine LearningHumansPrognosisGene Expression ProfilingMaleGene Expression Regulation, NeoplasticFemaleComputational BiologyROC CurveGene Regulatory NetworksKaplan-Meier EstimateAlgorithmsMiddle Aged

Stichwörter der Autor:innen

RT‐PCR and ELISAdiagnostic and prognostic potentialgastric cancerintegrated bioinformatics analysispromising biomarkers

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Institute of Artificial Intelligence Medicine, Shanghai Academy of Experimental Medicine, Shanghai, China.
  • Faculty of Medical Laboratory Science, College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ORCID-Profile: Hui Chen

Förderung

  • National Natural Science Foundation of China
  • Shanghai Key Clinical Specialty Construction Project
  • Shanghai Sailing Program

Zitieren

APA

Liu, Y., Bian, B., Chen, S., Zhou, B., Zhang, P., Shen, L., & Chen, H. (2025). Identification and Validation of Four Serum Biomarkers With Optimal Diagnostic and Prognostic Potential for Gastric Cancer Based on Machine Learning Algorithms. Cancer Medicine. https://doi.org/10.1002/cam4.70659

Vancouver

Liu Y, Bian B, Chen S, Zhou B, Zhang P, Shen L, et al. Identification and Validation of Four Serum Biomarkers With Optimal Diagnostic and Prognostic Potential for Gastric Cancer Based on Machine Learning Algorithms. Cancer Medicine. 2025. doi:10.1002/cam4.70659

BibTeX
@article{Liu2025,
  author = {Liu, Yi and Bian, Bingxian and Chen, Shiyu and Zhou, Bingqian and Zhang, Peng and Shen, Lisong and Chen, Hui},
  title = {Identification and Validation of Four Serum Biomarkers With Optimal Diagnostic and Prognostic Potential for Gastric Cancer Based on Machine Learning Algorithms},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.70659}
}
Kostenlos starten →